While the P values obtained from the univariate Cox analysis and the Kaplan–Meier method following PSM were close to significance, at 0.058 and 0.057 respectively (Fig. 3 D and Table 4 ), the multivariate Cox analysis demonstrated a statistically significant association between immunotherapy and enhanced survival prognosis (HR = 0.67; 95% CI: [0.38–0.92]; P = 0.015).
← all excerpts
Favorable outcome of immunotherapy use in metastatic HR+/HER2- breast cancer: a population-based cohort study.
1
—
—